China Aoxing Pharmaceutical (China Aoxing) has received the Good Manufacturing Practice (GMP) re-certification of four dosage forms, including capsule, tablet, granule and oral solution formulations, at its new manufacture and packaging facility.
The company said that the certificate of compliance has a five-year term and was issued by the State Food and Drug Administration (SFDA) following a site inspection.
Zhenjiang Yue, chairman and CEO of China Aoxing, said: “We are very pleased to obtain the GMP re-certification of four dosage forms, which is an important milestone in the process of our production facility consolidation.
“The re-certification will serve as a critical step to alleviate product backlog associated with these dosage forms. In addition, we expect more GMP re-certification of pill and tincture dosage forms at our brand new product facility in the first half of year 2010.”
Good Manufacturing Practice is a body of internationally accepted regulations set forth by drug agencies in many countries. GMP compliance ensures that pharmaceuticals, active ingredients and medical devices are produced and quality-controlled according to standards.